These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 8175131)
1. Effects of low-sodium diet and spironolactone on portal pressure in patients with compensated cirrhosis. García-Pagán JC; Salmerón JM; Feu F; Luca A; Ginés P; Pizcueta P; Claria J; Piera C; Arroyo V; Bosch J Hepatology; 1994 May; 19(5):1095-9. PubMed ID: 8175131 [TBL] [Abstract][Full Text] [Related]
2. Reduction of variceal pressure by propranolol: comparison of the effects on portal pressure and azygos blood flow in patients with cirrhosis. Feu F; Bordas JM; Luca A; García-Pagán JC; Escorsell A; Bosch J; Rodés J Hepatology; 1993 Nov; 18(5):1082-9. PubMed ID: 8225212 [TBL] [Abstract][Full Text] [Related]
3. Effects of propranolol on azygos venous blood flow and hepatic and systemic hemodynamics in cirrhosis. Bosch J; Masti R; Kravetz D; Bruix J; Gaya J; Rigau J; Rodes J Hepatology; 1984; 4(6):1200-5. PubMed ID: 6500511 [TBL] [Abstract][Full Text] [Related]
4. Chronic splanchnic hemodynamic effects of spironolactone with unrestricted sodium diet in patients with compensated cirrhosis. Sugano S; Kawafune T; Okajima T; Ishii K; Watanabe M; Takamura N Dig Dis Sci; 1998 Apr; 43(4):893-7. PubMed ID: 9558049 [TBL] [Abstract][Full Text] [Related]
5. Hemodynamic effects of glucagon in portal hypertension. Silva G; Navasa M; Bosch J; Chesta J; Pilar Pizcueta M; Casamitjana R; Rivera F; Rodés J Hepatology; 1990 Apr; 11(4):668-73. PubMed ID: 2328958 [TBL] [Abstract][Full Text] [Related]
6. Portal hypertension in patients with cirrhosis: indirect assessment of hepatic venous pressure gradient by measuring azygos flow with 2D-cine phase-contrast magnetic resonance imaging. Gouya H; Grabar S; Vignaux O; Saade A; Pol S; Legmann P; Sogni P Eur Radiol; 2016 Jul; 26(7):1981-90. PubMed ID: 26373753 [TBL] [Abstract][Full Text] [Related]
7. The hemodynamic effect of verapamil on portal hypertension in patients with postnecrotic cirrhosis. Kong CW; Lay CS; Tsai YT; Yeh CL; Lai KH; Lee SD; Lo KJ; Chiang BN Hepatology; 1986; 6(3):423-6. PubMed ID: 3710430 [TBL] [Abstract][Full Text] [Related]
8. Propranolol plus molsidomine vs propranolol alone in the treatment of portal hypertension in patients with cirrhosis. García-Pagán JC; Escorsell A; Feu F; Bandi JC; Moitinho E; Casado M; Bosch J; Rodés J J Hepatol; 1996 Apr; 24(4):430-5. PubMed ID: 8738729 [TBL] [Abstract][Full Text] [Related]
9. Propranolol compared with propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis. A randomized controlled study. García-Pagán JC; Feu F; Bosch J; Rodés J Ann Intern Med; 1991 May; 114(10):869-73. PubMed ID: 2014947 [TBL] [Abstract][Full Text] [Related]
10. [Blood flow and blood oxygen partial pressure of the azygos vein in portal hypertension evaluated by the catheter method]. Kimura T; Fuminori M; Kawasaki T; Someda H; Tamada T; Yamashita Y; Ono S; Hamato Y; Okuma M Nihon Shokakibyo Gakkai Zasshi; 1991 Feb; 88(2):145-52. PubMed ID: 2030559 [TBL] [Abstract][Full Text] [Related]
11. Hemodynamic effect of spironolactone in liver cirrhosis and propranolol-resistant portal hypertension. Sen S; De BK; Biswas PK; Biswas J; Das D; Maity AK Indian J Gastroenterol; 2002; 21(4):145-8. PubMed ID: 12385542 [TBL] [Abstract][Full Text] [Related]
13. Chronic splanchnic hemodynamic effects of low-dose transdermal nitroglycerin versus low-dose transdermal nitroglycerin plus spironolactone in patients with cirrhosis. Sugano S; Suzuki T; Nishio M; Makino H; Okajima T Dig Dis Sci; 1997 Mar; 42(3):529-35. PubMed ID: 9073134 [TBL] [Abstract][Full Text] [Related]
14. Effects of metoclopramide and domperidone on azygos venous blood flow in patients with cirrhosis and portal hypertension. Mastai R; Grande L; Bosch J; Bruix J; Rigau J; Kravetz D; Navasa M; Pera C; Rodés J Hepatology; 1986; 6(6):1244-7. PubMed ID: 3793001 [TBL] [Abstract][Full Text] [Related]
15. The acute and chronic effects of isosorbide-5-mononitrate on portal haemodynamics in cirrhosis. Grose RD; Plevris JN; Redhead DN; Bouchier IA; Hayes PC J Hepatol; 1994 Apr; 20(4):542-7. PubMed ID: 8051395 [TBL] [Abstract][Full Text] [Related]
17. Beta adrenergic stimulation and blockade in cirrhosis: effects on azygos vein blood flow and portal hemodynamics. Weinshel EH; Altszuler HM; Raicht RF; Sedlis SP Am J Med Sci; 1994 Jun; 307(6):396-400. PubMed ID: 7911005 [TBL] [Abstract][Full Text] [Related]
18. Portal and systemic hemodynamic responses to a very low dose of nitroglycerin in cirrhotic patients with portal hypertension. Kurokawa H; Sekiyama T; Katsuta Y; Aramaki T Nihon Ika Daigaku Zasshi; 1995 Feb; 62(1):2-12. PubMed ID: 7721974 [TBL] [Abstract][Full Text] [Related]
19. Noninvasive measurement of femoral blood flow and portal pressure response to propranolol in patients with cirrhosis. Luca A; García-Pagán JC; Feu F; Lopez-Talavera JC; Fernández M; Bru C; Bosch J; Rodés J Hepatology; 1995 Jan; 21(1):83-8. PubMed ID: 7806173 [TBL] [Abstract][Full Text] [Related]
20. Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: comparison with vasopressin. Bosch J; Kravetz D; Rodes J Gastroenterology; 1981 Mar; 80(3):518-25. PubMed ID: 6108897 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]